Skip to content

The Efficacy & Safety of rTMS for Upper-limb Motor Function Recovery in Subcortical and Brainstem Stroke

Multi-center, Prospective, Comparative, Randomized, Double Blind, Superior, Pivotal Study to Compare and Evaluate the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation Applied With an Electromagnetic Therapy Stimulator 'ALTMS-A' for Upper-limb Motor Function Recovery With the Sham Control Group for Those Who Need Upper-limb Rehabilitation Treatment for Subcortical and Brainstem Stroke (Ischemic)

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05535504
Enrollment
60
Registered
2022-09-10
Start date
2023-01-02
Completion date
2025-12-31
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia, Stroke, Subcortical Infarction

Keywords

Stroke, Transcranial magnetic stimulation, Rehabilitation, Neuronal plasticity, Subcortical infarction

Brief summary

The purpose of this study is to evaluate the efficacy and safety of repetitive transcranial magnetic stimulation applied with an electromagnetic therapy stimulator 'ALTMS-A' for upper-limb motor function recovery with the sham control group for those who need upper-limb rehabilitation treatment for subcortical and brainstem stroke

Detailed description

After low-frequency repetitive transcranial magnetic stimulation (rTMS) over the contralesional motor cortex (M1), the score of the Box and Block test increased immediately, especially in patients without cortical involvement. Eighty-eight patients will be recruited and divided into two groups. Each group will receive 10 sessions of the real rTMS or sham rTMS over the contralesional primary motor cortex. Each rTMS session consists of low-frequency (1Hz) 1800 stimulations. The objective of this study is to evaluate the efficacy and safety of rTMS for upper-limb motor function in patients with subcortical and brainstem stroke.

Interventions

DEVICELow-frequency rTMS (experimental)

Frequency: Low-frequency (1Hz) rTMS / Intensity: 100% of resting motor threshold / Location: motor hotspot of the contralesional primary motor cortex (the first dorsal interosseous muscle) / Number of total stimuli : 1800 ; Coil orientation: tangential to scalp

DEVICELow-frequency rTMS (sham comparator)

Frequency: Low-frequency (1Hz) rTMS / Intensity: 100% of resting motor threshold / motor hotspot of the contralesional primary motor cortex (the first dorsal interosseous muscle) / Number of total stimuli : 1800 ; Coil orientation: vertical to scalp

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER
Chungnam National University Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

ALTMS-A

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 19-80 years old * Radiologically confirmed ischemic stroke with subcortical and brainstem lesions within 90 days * Fugl-Meyer assessment scale (upper extremity) \> 15 * Mini-mental status exam (the Korean version) \> 14 with appropriate cognitive function * Written informed consent

Exclusion criteria

* Fugl-Meyer assessment scale (wrist) \< 1 or Fugl-Meyer assessment scale (hand) \< 1 * Hemorrhagic stroke or traumatic brain injury * Cerebellar stroke * Previous history of stroke * Traumatic brain injury * Previous history of brain surgery * Need for intensive care due to complications associated with stroke (e.g. pneumonia, infection, hemodynamic instability) * History of psychological or neurological diseases * History of pain or muscular weakness of upper limbs which may interfere with rehabilitation * History of seizure or epilepsy * Aphasia * Skin lesions in the stimulation site of scalp * Intracranial metal implant * Inability to receive regular physical or occupational therapy * Disagreement to use contraception in women of childbearing age

Design outcomes

Primary

MeasureTime frameDescription
Box and Block testupto 42 daysBefore rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS

Secondary

MeasureTime frameDescription
National Institutes of Health Stroke Scaleupto 42 daysBefore rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS
Finger tappingupto 42 daysBefore rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS
Box and Block testupto 14 daysBefore rTMS (baseline) and immediately after the completion of 10 sessions of rTMS
Fugl-Meyer Assessment Scaleupto 42 daysBefore rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS
Brunnstrom stage (hand and arm)upto 42 daysBefore rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS
Modified Ashworth scale (wrist flexor, wrist extensor, elbow flexor, elbow extensor, and finger flexor)upto 42 daysBefore rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS
Grip strength (hand grip, pinch grip, lateral prehension, three jaw chuck)upto 42 daysBefore rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS
modified Barthel Index (the Korean version)upto 42 daysBefore rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS

Other

MeasureTime frameDescription
Vital signupto 42 daysBefore rTMS (baseline), immediately after the completion of 10 sessions of rTMS, and 4 weeks after the completion of 10 sessions of rTMS

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026